Larvol Delta - Coya-Therapeutics-to-Present-Biomarker-and-Preliminary-Efcacy-Clinical-Data-for-COYA-301-for-the-Treatment-of-Patients-with-Alzheimers-Disease-AD-at-the-2023-Keystone-Symposia-Meeting-for-Neurodegeneration-held-on-May-1519th-2023

COYA 301 - Coya Therap

https://www.businesswire.com/news/home/20230331005102/en/Coya-Therapeutics-to-Present-Biomarker-and-Preliminary-Efficacy-Clinical-Data-for-COYA-301-for-the-Treatment-of-Patients-with-Alzheimer%E2%80%99s-Disease-AD-at-the-2023-Keystone-Symposia-Meeting-for-Neurodegeneration-held-on-May-15-19th-2023

Mar 31, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next